IL139166A0 - Anti- viral compounds - Google Patents

Anti- viral compounds

Info

Publication number
IL139166A0
IL139166A0 IL13916698A IL13916698A IL139166A0 IL 139166 A0 IL139166 A0 IL 139166A0 IL 13916698 A IL13916698 A IL 13916698A IL 13916698 A IL13916698 A IL 13916698A IL 139166 A0 IL139166 A0 IL 139166A0
Authority
IL
Israel
Prior art keywords
viral compounds
viral
compounds
Prior art date
Application number
IL13916698A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL139166A0 publication Critical patent/IL139166A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
IL13916698A 1998-05-20 1998-05-20 Anti- viral compounds IL139166A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/010299 WO1999059587A1 (en) 1998-05-20 1998-05-20 Anti-viral compounds

Publications (1)

Publication Number Publication Date
IL139166A0 true IL139166A0 (en) 2001-11-25

Family

ID=22267098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13916698A IL139166A0 (en) 1998-05-20 1998-05-20 Anti- viral compounds

Country Status (15)

Country Link
EP (1) EP1077701A4 (en)
JP (1) JP2002515433A (en)
KR (1) KR20010025055A (en)
CN (1) CN1292697A (en)
AU (1) AU7583098A (en)
BR (1) BR9815899A (en)
CA (1) CA2332403A1 (en)
CZ (1) CZ289425B6 (en)
EA (1) EA200001208A1 (en)
HU (1) HUP0102117A2 (en)
IL (1) IL139166A0 (en)
NO (1) NO20005795L (en)
SK (1) SK17482000A3 (en)
TR (1) TR200003414T2 (en)
WO (1) WO1999059587A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AR048650A1 (en) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION
WO2006020830A2 (en) 2004-08-12 2006-02-23 Amgen Inc. Bisaryl-sulfonamides
KR101300831B1 (en) * 2005-03-21 2013-08-30 에스*바이오 피티이 리미티드 IMlDAZO[1,2-a]PYRIDINE DERⅣATⅣES, PREPARATION AND PHARMACEUTICAL APPLICATIONS
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
ES2378473T3 (en) 2005-12-21 2012-04-12 Abbott Laboratories Antiviral compounds
EP1971611B1 (en) 2005-12-21 2012-10-10 Abbott Laboratories Anti-viral compounds
US7763731B2 (en) 2005-12-21 2010-07-27 Abbott Laboratories Anti-viral compounds
TWI399380B (en) 2006-12-20 2013-06-21 Abbott Lab Anti-viral compounds
US8580791B2 (en) * 2008-05-27 2013-11-12 Biota Scientific Management Pty Ltd Antiviral 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole bis-dihydrogen-phosphate salts
CN102264737A (en) 2008-12-23 2011-11-30 雅培制药有限公司 Anti-viral compounds
CN102245604A (en) 2008-12-23 2011-11-16 雅培制药有限公司 Anti-viral compounds
EP2419404B1 (en) * 2009-04-15 2015-11-04 AbbVie Inc. Anti-viral compounds
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
EP2914587A1 (en) 2012-10-31 2015-09-09 Bayer CropScience AG Novel heterocyclic compounds as pest control agents
CN104370732B (en) * 2014-01-26 2015-08-19 山东信立泰药业有限公司 The preparation method of a kind of clopidogrel and intermediate thereof
CN109535405B (en) * 2017-09-21 2021-07-30 宁波聚嘉新材料科技有限公司 Preparation method of polyarylate based on 2- (4-carboxyphenyl) -5-hydroxypyridoimidazole
CN109810085B (en) * 2019-04-19 2019-07-19 上海皓元生物医药科技有限公司 The preparation method of ACC inhibitor and its intermediate
CN110746450A (en) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 Synthetic method of beraprost sodium key intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
KR20000016346A (en) * 1996-06-05 2000-03-25 피터 지. 스트링거 Antiviral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds

Also Published As

Publication number Publication date
WO1999059587A1 (en) 1999-11-25
AU7583098A (en) 1999-12-06
CN1292697A (en) 2001-04-25
BR9815899A (en) 2001-02-20
NO20005795D0 (en) 2000-11-16
HUP0102117A2 (en) 2001-12-28
EP1077701A1 (en) 2001-02-28
EP1077701A4 (en) 2002-03-20
CZ20004278A3 (en) 2001-05-16
CZ289425B6 (en) 2002-01-16
KR20010025055A (en) 2001-03-26
TR200003414T2 (en) 2001-03-21
CA2332403A1 (en) 1999-11-25
JP2002515433A (en) 2002-05-28
NO20005795L (en) 2001-01-18
EA200001208A1 (en) 2001-06-25
SK17482000A3 (en) 2005-03-04

Similar Documents

Publication Publication Date Title
GB9804734D0 (en) Compounds
GB9804175D0 (en) Compounds
IL139166A0 (en) Anti- viral compounds
GB9818689D0 (en) Compounds
GB9818881D0 (en) Compounds
EP1001767A4 (en) Anti-viral compounds
GB9809823D0 (en) Compounds
GB9810876D0 (en) Compounds
GB9812522D0 (en) Compounds
GB9801712D0 (en) Compounds
GB9809217D0 (en) Compounds
PL344262A1 (en) Anti-viral compounds
GB9804337D0 (en) Anti-viral compounds
GB9906211D0 (en) Anti-viral compounds
GB9809609D0 (en) Anti-viral compounds
GB9720837D0 (en) Anti-viral compounds
GB9623132D0 (en) Anti-viral guanidino-substituted compounds
GB9609306D0 (en) Anti-viral compounds
GB9806699D0 (en) Compounds
GB9801100D0 (en) Compounds
GB9805447D0 (en) Compounds
GB9806379D0 (en) Compounds
GB9806690D0 (en) Compounds
GB9805133D0 (en) Compounds
GB9806701D0 (en) Compounds